Related Experiment Video
Updated: Jun 21, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions
Jessica Magid-Bernstein1, Romuald Girard2, Sean Polster2
1Department of Neurology, Yale University School of Medicine, New Haven, CT (J.M.-B., L.H.S.).
Insights
Intracerebral hemorrhage (ICH), a severe stroke type, is rising globally. Current treatments offer limited improvement, but new research in biomarkers, prevention, and therapies like minimally invasive surgery offers future hope.
Area of Science:
- Neurology
- Stroke Medicine
- Neurosurgery
Background:
- Intracerebral hemorrhage (ICH) is a major cause of stroke-related death and disability.
- Global ICH incidence has risen over 40 years, influenced by improved hypertension control and increased anticoagulant use.
- Understanding ICH pathophysiology involves edema, inflammation, iron toxicity, and oxidative stress.
Purpose of the Study:
- To review the epidemiology, causes, injury mechanisms, and current treatments for intracerebral hemorrhage.
- To explore promising future research directions and novel therapeutic strategies for ICH management.
Main Methods:
- Comprehensive review of existing preclinical and clinical trial data on intracerebral hemorrhage.
- Analysis of epidemiological trends and shifts in ICH causes.
- Evaluation of current medical and surgical management strategies.
Main Results:
- ICH incidence is increasing worldwide, with evolving causative factors.
- Established treatments have not significantly improved survival or functional outcomes.
- Mechanisms of injury involve complex interactions including edema, inflammation, and oxidative stress.
Conclusions:
- Despite challenges, ongoing research into prognostic biomarkers, primary prevention, ultra-early hemostatic therapy, and minimally invasive surgery offers hope for improved ICH outcomes.
- Future therapeutic approaches focus on addressing the complex pathobiology of ICH, including neuroprotection and targeted interventions.
Abstract:
Intracerebral hemorrhage (ICH) is a devastating form of stroke with high morbidity and mortality. This review article focuses on the epidemiology, cause, mechanisms of injury, current treatment strategies, and future research directions of ICH. Incidence of hemorrhagic stroke has increased worldwide over the past 40 years, with shifts in the cause over time as hypertension management has improved and anticoagulant use has increased. Preclinical and clinical trials have elucidated the underlying ICH cause and mechanisms of injury from ICH including the complex interaction between edema, inflammation, iron-induced injury, and oxidative stress. Several trials have investigated optimal medical and surgical management of ICH without clear improvement in survival and functional outcomes. Ongoing research into novel approaches for ICH management provide hope for reducing the devastating effect of this disease in the future. Areas of promise in ICH therapy include prognostic biomarkers and primary prevention based on disease pathobiology, ultra-early hemostatic therapy, minimally invasive surgery, and perihematomal protection against inflammatory brain injury.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

